Skip to main content

Table 1 IGF-I production in rAAV-transduced chondrocytes in vitro and in situ.

From: Benefits of Recombinant Adeno-Associated Virus (rAAV)-Mediated Insulinlike Growth Factor I (IGF-I) Overexpression for the Long-Term Reconstruction of Human Osteoarthritic Cartilage by Modulation of the IGF-I Axis

 

d

Normal chondrocytes

OA chondrocytes

  

rAAV-lacZ

rAAV-hIGF-I

rAAV-lacZ

rAAV-hIGF-I

Monolayer cultures (ng/107 viable cells/24 h)

     
 

5

3.40 (0.08)

29.30 (0.81)a

2.60 (0.05)

18.87 (0.92)a

 

10

0.08 (0.01)

27.03 (0.70)a

0.06 (0.01)

18.89 (0.68)a

 

20

n.d.

21.84 (0.53)a

n.d.

16.68 (0.64)a

Alginate cultures (ng/107 viable cells/24 h)

     
 

5

2.70 (0.03)

25.02 (0.22)a

3.75 (0.02)

24.73 (0.09)a

 

26

n.d.

24.60 (0.16)a

n.d.

22.79 (0.13)a

Explant cultures (pg/mg dry weight/24 h)

     
 

5

0.42 (0.06)

16.97 (1.22)a

0.27 (0.03)

14.14 (1.02)a

 

12

0.12 (0.04)

13.61 (1.16)a

0.10 (0.05)

12.71 (1.01)a

 

30

0.09 (0.02)

26.24 (2.31)a

0.16 (0.03)

29.23 (1.58)a

 

60

0.14 (0.03)

26.82 (1.98)a

0.11 (0.02)

28.91 (2.06)a

 

90

0.11 (0.03)

32.41 (1.84)a

0.09 (0.03)

37.20 (2.12)a

  1. Data are means (SD). n.d., Not detectable.
  2. aStatistically significant vis-à-vis control treatment.